Journey Medical Corp Cash Flow Reinvestment Rate
Journey Medical Corp cash flow reinvestment rate. Journey Medical Corp (DERM) has a Cash Flow Reinvestment Rate of 6.74x as of December 2024, reinvesting $15.00 Million (capex $0.00 plus investments $-15.00 Million) from operating cash flow of $2.23 Million. Explore DERM cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Journey Medical Corp (2019–2023)
Cash flow reinvestment rate of Journey Medical Corp from 2019 to 2023. Historical reinvestment intensity for Journey Medical Corp across 3 annual periods. Explore Journey Medical Corp capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Journey Medical Corp Cash Flow Reinvestment Rate by Year (2019–2023)
Journey Medical Corp cash flow reinvestment rate by year from 2019 to 2023. Year-by-year capital reinvestment analysis for Journey Medical Corp. For the full cash flow conversion analysis, see how efficiently does Journey Medical Corp generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.91x | $10.00 Million | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.47x | $2.40 Million | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.53x | $4.80 Million | $9.02 Million | $2.40 Million | — |